Connection

M ATASSI to Immunization

This is a "connection" page, showing publications M ATASSI has written about Immunization.
Connection Strength

1.279
  1. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Aug; 50(5):293-305.
    View in: PubMed
    Score: 0.122
  2. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Sci Rep. 2015 Oct 28; 5:15776.
    View in: PubMed
    Score: 0.109
  3. Regions recognized on the light chain of botulinum neurotoxin type A by T lymphocytes of SJL and BALB/c mice primed with inactivated toxin. Immunobiology. 2014 Dec; 219(12):950-7.
    View in: PubMed
    Score: 0.100
  4. Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin A. Immunol Lett. 2012 Feb 29; 142(1-2):20-7.
    View in: PubMed
    Score: 0.083
  5. Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates. Immunol Lett. 2011 Jun 30; 137(1-2):46-52.
    View in: PubMed
    Score: 0.079
  6. On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology (Reading). 2006 Jul; 152(Pt 7):1891-1895.
    View in: PubMed
    Score: 0.057
  7. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A. Mol Immunol. 2005 Aug; 42(12):1509-20.
    View in: PubMed
    Score: 0.052
  8. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains. Immunol Invest. 2005; 34(2):119-42.
    View in: PubMed
    Score: 0.052
  9. Basic immunological aspects of botulinum toxin therapy. Mov Disord. 2004 Mar; 19 Suppl 8:S68-84.
    View in: PubMed
    Score: 0.049
  10. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest. 2002 Aug-Nov; 31(3-4):247-62.
    View in: PubMed
    Score: 0.044
  11. Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc. Immunol Lett. 1998 Jan; 60(1):7-12.
    View in: PubMed
    Score: 0.032
  12. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products. Autoimmunity. 1998; 27(2):79-90.
    View in: PubMed
    Score: 0.032
  13. Intersite helper function of T cells specific for a protein epitope that is not recognized by antibodies. Immunol Invest. 1997 Jun; 26(4):473-89.
    View in: PubMed
    Score: 0.030
  14. Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid. Immunol Invest. 1997 Jun; 26(4):491-504.
    View in: PubMed
    Score: 0.030
  15. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol. 1996 Oct 01; 157(7):3192-9.
    View in: PubMed
    Score: 0.029
  16. Antibody and T-cell recognition of alpha-bungarotoxin and its synthetic loop-peptides. Mol Immunol. 1995 Aug; 32(12):919-29.
    View in: PubMed
    Score: 0.027
  17. Profile of the regions of acetylcholine receptor alpha chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor. Mol Immunol. 1994 Aug; 31(11):833-43.
    View in: PubMed
    Score: 0.025
  18. Mapping of the polypeptide chain organization of the main extracellular domain of the alpha-subunit in membrane-bound acetylcholine receptor by antipeptide antibodies spanning the entire domain. Adv Exp Med Biol. 1994; 347:221-8.
    View in: PubMed
    Score: 0.024
  19. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance. Adv Exp Med Biol. 1994; 347:65-75.
    View in: PubMed
    Score: 0.024
  20. Biological activities of rat antisera raised against synthetic peptides of human thyrotropin receptor. Endocr J. 1993 Oct; 40(5):607-12.
    View in: PubMed
    Score: 0.024
  21. Amino acid substitutions outside a preselected antigenic region in hemoglobin affect the binding to monoclonal antibodies obtained by immunization with the synthetic region. J Protein Chem. 1993 Aug; 12(4):403-12.
    View in: PubMed
    Score: 0.023
  22. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 113-120 (antigenic site 4) of myoglobin. J Protein Chem. 1992 Dec; 11(6):677-86.
    View in: PubMed
    Score: 0.022
  23. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 145-151 (antigenic site 5) of myoglobin. J Protein Chem. 1992 Dec; 11(6):687-98.
    View in: PubMed
    Score: 0.022
  24. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 94-100 (antigenic site 3) of myoglobin. J Protein Chem. 1992 Oct; 11(5):433-44.
    View in: PubMed
    Score: 0.022
  25. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 15-22 (antigenic site 1) of myoglobin. J Protein Chem. 1992 Oct; 11(5):445-54.
    View in: PubMed
    Score: 0.022
  26. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 56-62 (antigenic site 2) of myoglobin. J Protein Chem. 1992 Oct; 11(5):455-65.
    View in: PubMed
    Score: 0.022
  27. Generation of species-specific antihemoglobin antibodies by immunization with synthetic peptides of human hemoglobin. J Protein Chem. 1989 Dec; 8(6):767-78.
    View in: PubMed
    Score: 0.018
  28. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J Neuroimmunol. 2006 Jun; 175(1-2):107-17.
    View in: PubMed
    Score: 0.014
  29. T-cell recognition of lysozyme. I. Localization of regions stimulating T-cell proliferative response by synthetic overlapping peptides encompassing the entire molecule. Exp Clin Immunogenet. 1984; 1(2):99-111.
    View in: PubMed
    Score: 0.012
  30. Antibodies with specificities to preselected protein regions evoked by free synthetic peptides representing protein antigenic sites or other surface locations: demonstration with myoglobin. Mol Immunol. 1983 May; 20(5):567-70.
    View in: PubMed
    Score: 0.011
  31. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1983 Feb; 80(3):840-4.
    View in: PubMed
    Score: 0.011
  32. Antibodies with preselected specificities to protein regions evoked by immunization with free synthetic peptides: dose response to myoglobin antigenic sites reveal an optimum dose for each antigenic site. Immunol Commun. 1983; 12(4):419-28.
    View in: PubMed
    Score: 0.011
  33. Antibodies to sperm-whale myoglobin evoked by free synthetic peptides of an antigenic site. Immunol Commun. 1982; 11(1):9-16.
    View in: PubMed
    Score: 0.010
  34. Immune recognition of serum albumin--XIII. Autoreactivity with rabbit serum albumin of rabbit antibodies against bovine or human serum albumins and autoimmune recognition of rabbit serum albumin. Mol Immunol. 1981 Nov; 18(11):961-7.
    View in: PubMed
    Score: 0.010
  35. Immunochemistry of serum albumin--V. A time-dependent examination of the antibody response to bovine serum albumin by the activity of its third domain. Mol Immunol. 1979 Jul; 16(7):451-6.
    View in: PubMed
    Score: 0.009
  36. Enzymic and immunochemical properties of lysozyme. V. Derivatives modified at lysine residues by guanidination, acetylation, succinylation or maleylation. Immunochemistry. 1971 Nov; 8(11):1047-59.
    View in: PubMed
    Score: 0.005
  37. Periodate oxidation of sperm-whale myoglobin and the role of the methionine residues in the antigen-antibody reaction. Biochem J. 1967 Feb; 102(2):478-87.
    View in: PubMed
    Score: 0.004
  38. Reaction of myoglobin with 3,3-tetramethyleneglutaric anhydride. Biochem J. 1967 Feb; 102(2):488-91.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.